Introduction
============

The generation of mammalian follicles is a continuous and complex process in which primordial follicles develop into pre-ovulatory follicles [@B1]. Normally, only a limited number of follicles undergo this process and release oocytes, while the majority of follicles undergo atresia at different developmental stages [@B2]. Granulosa cells (GCs) act as important mediators in ovarian follicle development and provide necessary growth factors and specific proteins to the oocytes, and the proliferation of GCs triggers the follicular growth and oocyte maturation [@B3],[@B4]. The complexity of folliculogenesis indicates that tightly regulated gene expression and interactions between many genes are necessary for successful oocyte development [@B5]. However, the definitive regulatory mechanism underlying follicular development and GC proliferation remains unclear.

MiRNAs, a class of endogenous noncoding RNAs 19-23 nucleotides in length, regulate the expression level of target genes by complementary binding to the 3′-untranslated region (3′-UTR) of target genes thereby mediating translation inhibition or RNA degradation [@B6],[@B7]. MiRNAs play crucial roles in numerous cellular processes, including follicular development and atresia, cell proliferation, and apoptosis [@B8]-[@B11]. The previous results of our laboratory showed that miR-27a was differentially expressed in pre-ovulatory ovarian follicles between Chinese Taihu and Large White sows [@B12]. And we previously reported that miR-27a suppressed CHO cell proliferation by downregulating DKK2 expression [@B5]. Thus, miR-27a has always been the focus of our research.

The Wnt signaling pathway is a main regulator of development in animals [@B13]. Wnt signaling plays roles in fetal and ovarian development, gestation, and mammogenesis [@B14]-[@B15]. Our previous studies have focused on Wnt signaling pathway, and investigated the regulation mechanism of Wnt signaling genes [@B5],[@B16]. p53 and nuclear factor of activated T-cells 5 (NFAT5) are two members of the Wnt signaling pathway. Moreover, the interaction among p53, miR-27a and NFAT5 was predicted by bioinformatics methods. Numerous studies have shown that p53 has a key role in tumor prevention [@B17]. Moreover, the pregnancy rate and litter size of p53^-/-^ female mice are significantly decreased. This indicates the important effect of p53 on mammalian reproduction [@B18]. NFAT5, as a transcription factor, is a member of the Rel family and is involved in multiple biological processes, including embryonic development, cellular migration, and proliferation [@B19]. Nevertheless, the function of NFAT5 in GCs is largely unknown.

Previously, we showed that miR-27a suppressed Chinese hamster ovary (CHO) cell proliferation by downregulating expression of the Wnt antagonist, Dickkopf-related protein 2 (DKK2) [@B5]. The purpose of this study was to further analyze how the key genes of Wnt signaling pathway regulate miR-27a and how they are regulated by miR-27a. In the current study, we report that p53-mediated suppression of miR-27a increased the expression level of the target gene, NFAT5. We also demonstrated that *NFAT5* induced sustained Wnt pathway activation through enhancing the expression of β-catenin and B-cell lymphoma/leukemia-2 (Bcl-2), thus facilitating mouse GC proliferation. Taken together, our results reveal a novel p53/miR-27a/NFAT5 pathway, and NFAT5 contributes to the proliferation of mouse GCs via activating Wnt signaling pathway.

Results
=======

miR-27a is highly conserved in mammals
--------------------------------------

Mature sequences of miR-27a are highly conserved in mammals, including mice, rats, humans, hamsters, cattle, goats, chimpanzees, gorillas, horses, and pigs. The seed sequences of miR-27a were identical, although there were one or two base deletions at the end of the mammalian sequence (Figure [1](#F1){ref-type="fig"}A). Clustal Omega, a new multiple sequence alignment program, was used to build the phylogenetic tree of the pre-miRNA of miR-27a. The results revealed that, compared with the other species examined, the genetic relationships between mice and rats, cattle and goats, and humans and gorillas, were closer (Figure [1](#F1){ref-type="fig"}B).

*p53* represses expression of miR-27a
-------------------------------------

The most prominent property of the p53 protein is its action as a transcription factor because it possesses a functional transactivation domain [@B20]. To determine whether p53 regulated the expression level of pre-miR-27a, mouse *p53* cDNA (NM_001127233.1) was cloned into *pcDNA3.1*(+), named *pc-p53*. The *pc-p53* plasmid and p53 siRNA (si-p53) were transfected into CHO-K1 cells. The quantitative real-time polymerase chain reaction (qRT-PCR) and western blot analyses revealed that*p53* overexpression significantly promoted p53 mRNA and protein expression, respectively (*P* \< 0.001). Transfection of si-p53 knocked down p53 mRNA and protein expression (*P* \< 0.001) (Figure [2](#F2){ref-type="fig"}A, B), indicating that the recombinant plasmid in *pc-p53* was expressed successfully.

The expression level of mature miR-27a was detected and significantly suppressed by p53 (Figure [2](#F2){ref-type="fig"}C). To confirm the repressive effect of p53 on miR-27a expression, we knocked down p53. This led to the increased expression of miR-27a (Figure [2](#F2){ref-type="fig"}C). These results demonstrated that miR-27a was downregulated by *p53*.

The miR-27a promoter contains *p53* response elements
-----------------------------------------------------

To identify the promoter of mouse miR-27a, a potential promoter (-1039 to -1 bp) was used to drive luciferase gene expression, and luciferase activity was determined. *pGL3* plasmids containing the potential miR-27a promoter (*miR-27a-promoter*) were transiently transfected into CHO-K1 cells. The results revealed that a *miR-27a-promoter* vector was required for miR-27a transcriptional activity (Figure [3](#F3){ref-type="fig"}A). This demonstrates that the region from -1039 to -1 bp contains one or more cis-acting elements that could regulate miR-27a expression.

To determine whether p53 is a verifiable transcription factor of miR-27a in vivo, binding site analysis with the TFBIND program revealed eleven putative p53 binding sites on the miR-27a promoter (Figure [3](#F3){ref-type="fig"}B). These p53 binding sites share highly conserved nucleotides with consensus sequences that can be depicted as RRXCXXGXYX-N^0-13^-XRXCXXGXYY, where R = A/G, Y = C/T, and X = A/G/C/T [@B21].

To identify p53 binding sites on the miR-27a promoter, we used luciferase assays to analyze the relationship between p53 and miR-27a. *pc-p53* and *pcDNA3.1*, si-p53, and a nonsense control (NC) were co-transfected with the *miR-27a-promoter* vector into CHO-K1 cells. Overexpression of *p53* significantly suppressed miR-27a promoter activity. In contrast, knockdown of *p53* increased miR-27a promoter activity (Figure [3](#F3){ref-type="fig"}C).

The transcription factor p53 binds to the miR-27a promoter in vitro and in vivo
-------------------------------------------------------------------------------

To confirm that p53 can bind to the promoter of mouse miR-27a, ten mutant pGL3 reporter constructs in which putative binding sites 1 (-1022 to -1013 bp), 2 (-853 to -844 bp), 3 (-801 to -787 bp), 4 (-646 to -637 bp), 5 (-553 to -544 bp), 6 (-451 to -442 bp), 7 (-403 to -394 bp), 8 (-250 to -241 bp) and 9 (-246 to -237 bp), 10 (-50 to -41 bp), and 11 (-17 to -8 bp) were created using site-directed mutagenesis. Sites 8 and 9 had overlapping sequences. Thus, they only yielded one mutant vector. Luciferase activity analysis of CHO-K1 cells revealed that mutating binding sites 4, 6, and 10 of the miR-27a promoter caused a substantial increase in promoter activity, while the mutating binding site 11 showed the opposite result (Figure [3](#F3){ref-type="fig"}D).

ChIP assays were performed in CHO-K1 cells to determine whether p53 could bind to binding sites 4, 6, and 10 of the miR-27a promoter in vivo. Chromatin was immunoprecipitated using a p53 antibody, and DNA fragments of the expected size were used as templates to perform qRT-PCR. As shown in Figure [3](#F3){ref-type="fig"}E, p53 interacted with the miR-27a promoter within binding sites 4 (-646 to -637 bp) and 10 (-50 to -41 bp). These results confirmed that the transcription factor p53 was capable of binding to these two binding sites in the mouse miR-27a promoter region, and repress miR-27a transcription.

miR-27a directly targets *NFAT5*
--------------------------------

TargetScan was used to explore potential targets for miR-27a. A putative binding site for miR-27a was predicted in the 3′-UTR of *NFAT5*. In addition, the miR-27a binding seed sequence (ACUGUGA) in the *NFAT5* 3′-UTR was very highly conserved in mammals, including mice, rats, humans, chimpanzees, rhesus monkeys, rabbits, elephants, opossums, and squirrels (Figure [4](#F4){ref-type="fig"}A, B).

A dual-luciferase reporter system was used to analyze the interaction between miR-27a and *NFAT5*. We co-transfected miR-27a mimics and a dual-luciferase reporter recombinant plasmid (*pmirGLO-NFAT5*) containing the mouse 620 bp *NFAT5* 3′-UTR region into CHO-K1 cells. The results showed that the luciferase activity of *pmirGLO-NFAT5* was significantly suppressed by miR-27a (Figure [4](#F4){ref-type="fig"}C). However, luciferase activity was unchanged when we co-transfected miR-27a mimics and *pmirGLO-NFAT5-mut* into CHO-K1 cells (Figure [4](#F4){ref-type="fig"}C). qRT-PCR and western blot analyses revealed that NFAT5 mRNA and protein expression levels were significantly suppressed after miR-27a mimics were transfected into CHO-K1 cells, whereas inhibition of miR-27a increased NFAT5 mRNA and protein expression levels (Figure [4](#F4){ref-type="fig"}D, E). Our data suggested that miR-27a required the 3′-UTR of *NFAT5* to regulate its expression levels.

Relationship between *NFAT5* and Wnt pathway
--------------------------------------------

*NFAT5* is a regulator of Wnt signaling [@B22]. Thus, we hypothesized that it might play this role by regulating β-catenin and Bcl-2 expression. To test our hypothesis, mouse *NFAT5* cDNA (NM_018823.2) was cloned into the *pcDNA3.1* vector. The *pc-NFAT5* plasmid was then transfected into CHO-K1 cells. *NFAT5* overexpression significantly promoted the expression level of NFAT5 mRNA and protein, as determined using qRT-PCR and western blot analyses, respectively (*P* \< 0.001). Furthermore, siRNA of*NFAT5* (si-NFAT5) decreased NFAT5 mRNA and protein in CHO-K1 cells (Figures [5](#F5){ref-type="fig"}A, B). These results indicated that the recombinant plasmid and siRNA of *pc-NFAT5* were successfully expressed.

Along with overexpression of *NFAT5*, mRNA and protein levels of the Wnt signaling genes, β-catenin and Bcl-2, were strongly upregulated, whereas suppression of *NFAT5* decreased these levels (Figure [5](#F5){ref-type="fig"}C-E). These results suggest that *NFAT5* may enhance Wnt signaling by promoting the expression of β-catenin and Bcl-2.

*NFAT5* promotes cells proliferation in mouse GCs
-------------------------------------------------

GCs proliferation is ultimately important in follicular growth and oocyte maturation [@B3]. To study the effect of *NFAT5* on the proliferation of GCs, we performed an EdU cell proliferation assay. Mouse GCs were transfected with the *pc-NFAT5* or *pcDNA3.1* plasmid. *NFAT5* overexpression noticeably accelerated proliferation of GCs (Figure [6](#F6){ref-type="fig"}A). Quantitative analysis demonstrated that this change was statistically significant (*P* \< 0.001) (Figure [6](#F6){ref-type="fig"}B). Taken together, these results suggest that the miR-27a target gene, NFAT5, may promote GC proliferation. EdU (red)/Hoechst (blue) immunostaining further confirmed this conclusion.

Discussion
==========

Folliculogenesis is a complex biological process. GCs provide necessary material to oocytes and play vital roles in ovarian follicle development. However, the definitive regulatory mechanism underlying follicular development and GC proliferation remains unclear.

MiRNAs, a type of small non-coding RNA, modulate the expression of protein-coding genes at the post-transcriptional level. The regulatory mechanism(s) of miRNAs in folliculogenesis has becomes an important area of research. Numerous previous studies have indicated that miRNAs have a vital role in folliculogenesis. miR-144 promotes mouse GC apoptosis and affects follicular atresia through the miR-144/cyclooxygenase-2/prostaglandin E2 pathway [@B12]. miR-125a-3p is involved in mural granulosa cell migration prior to ovulation, and interfering with this signal in vivo hampers ovulation [@B23]. In addition, miR-21 regulates apoptosis in mouse periovulatory granulosa cells [@B24].

Our laboratory previously used Solexa sequencing to show that miR-27a was differentially expressed in pre-ovulatory ovarian follicles between Chinese Taihu and Large White sows [@B12]. By sequence analysis, we found that mature sequences of miR-27a were highly conserved in mammals (Figure [1](#F1){ref-type="fig"}A). In addition to diseases [@B25],[@B26], miR-27a has a vital role in follicular development because it regulates numerous target genes. For example, miR-27a targets *SMAD5* and regulates human GC apoptosis via the FasL-Fas pathway [@B27]. miR-27a, which is differential expressed between human GCs from MI and MII oocytes, decreases the maturation rate of oocytes [@B28]. Furthermore, we previously reported that miR-27a suppresses CHO cell proliferation by downregulating DKK2 expression [@B5]. Thus, miR-27a has always been the focus of our research.

We have been focusing on the regulation of follicular development by the Wnt signaling pathway axis and miRNA. The Wnt transduction cascade is a crucial regulator in animal development [@B13]. Fittingly, the transcription factor (p53) and target gene (NFAT5) of miR-27a are downstream of the Wnt signaling pathway.

Several previous studies have demonstrated that miRNA expression is regulated by many transcription factors [@B29],[@B30]. *p53*, the most extensively studied oncogene, codes for a sequence-specific DNA binding protein that regulates transcription [@B31],[@B32]. The p53 protein is composed of two N-terminal transactivation domains, a central DNA binding domain, a tetramerization domain, and a C-terminus regulatory domain [@B33]. The DNA binding domain binds specifically to the cis-acting element of target genes and regulates gene transcriptional activity. To assess the transcription factors binding to the miR-27a promoter, eleven *p53* binding sites were identified in the miR-27a promoter region using TFBIND software (Figure [3](#F3){ref-type="fig"}B). Importantly, the results of our study indicated that *p53* bound directly to the miR-27a promoter and repressed its transcriptional activation. In contrast, another study found that the abundance of miR-27a was significantly increased after p53 activation in human cancer cells [@B34]. Mutant, but not wild-type p53 directly bound to the miR-27a promoter and repressed miR-27a transcription in H1299 cells [@B35]. The results of both previous studies are contrary to our observations that suggest the regulatory effect of p53 on miR-27a is entirely different in normal and cancerous cells. In addition, several other studies indicated that miR-27a could bind to the *p53* 3′-UTR and decrease the endogenous *p53* expression level [@B36]-[@B38]. Moreover, luciferase activity analysis revealed that mutating binding site 6 of the miR-27a promoter caused the highest promoter activity (Figure [3](#F3){ref-type="fig"}D). But curiously, the result of ChIP assay showed that p53 could not bind to binding site 6 of the miR-27a promoter in vivo. Although the transcription factor p53 cannot bind to the predicted p53 binding sites, the p53 binding sites may regulate the transcription activity of miR-27 by altering the binding of other adjacent transcription factors. Previous study could support the above viewpoint [@B39]. Binding site 11 showed the opposite result which mutating binding site 11 caused a lower promoter activity compared to control group (Figure [3](#F3){ref-type="fig"}D). We thought the cause might be that the site mutations form a new unknown transcription factor binding site which inhibits the promoter activity of miR-27a.

The expression of β-catenin and Bcl-2 as signals of the WNT signaling pathway was determined due to their relationship with folliculogenesis. β-Catenin regulates GC differentiation, and its over-activation leads to a Sertoli-to-granulosa-like cell transformation [@B40]. Bcl-2 overexpression increases the number of primordial follicles [@B41], while its downregulation is involved in GC apoptosis which was induced by autophagosome accumulation [@B42]. Thus, we chose β-catenin and Bcl-2 as target genes for folliculogenesis. Our results demonstrated that miR-27a downregulated the target gene, NFAT5 (Figure [4](#F4){ref-type="fig"}D, E), which promoted the expression of β-catenin and Bcl-2, as well as GC proliferation (Figures [5](#F5){ref-type="fig"}, 6). Our findings may provide a new p53/miR-27a/NFAT5 axis, and NFAT5 regulates mouse granulosa cell functions via activating Wnt signaling pathway (Figure [7](#F7){ref-type="fig"}).

Taken together, our results demonstrate that *NFAT5* has a crucial role in GC proliferation and enhances the Wnt pathway via upregulating the expression of β-catenin and Bcl-2. In addition, *NFAT5* is downregulated by the p53/miR-27a axis (Figure [7](#F7){ref-type="fig"}). These results suggest that a novel signaling pathway p53/miR-27a/NFAT5 is involved, and NFAT5 contributes to the proliferation of mouse GCs via activating Wnt signaling pathway. These conclusions have potential implications in improving follicular development through modifying the p53/miR-27a/NFAT5 pathway.

Materials and Methods
=====================

Cell culture
------------

Mouse granulosa cells from pre-ovulatory ovarian follicles were obtained from murine ovaries after Kunming White female mice were treated for 48 h with 10 IU PMSG (SanSheng, China). The CHO-K1 cells were obtained from the China Centre for Type Culture Collection (Shanghai, China). Cells were cultured with Dulbecco\'s minimum essential medium/nutrient F-12 (DMEM/F-12) (Gibco, USA) supplied with 10% foetal bovine serum (Gibco) at 37 °C in a humidified atmosphere of 5% CO~2~.

Transfection and Dual-luciferase reporter assays
------------------------------------------------

The Granulosa cells or CHO-K1 cells were plated and grown until they were 70-80% confluent at the time of transfection. miRNA or siRNA was transfected into the cells using Lipofectamine RNAiMAX Reagent (Invitrogen, USA). Plasmids were transfected into the cells using Lipofectamine 3000 (Invitrogen, USA). For dual-luciferase reporter assays, each wild-type or promoter region construct was transfected into the cells at 500 ng, together with 10 ng/well of pRL-TK (Promega, USA). After transfection for 24 h, the luciferase activities were measured with a PerkinElmer 2030 Multilabel Reader (PerkinElmer, USA).

Sequence analysis
-----------------

Clustal Omega (Available online: <https://www.ebi.ac.uk/Tools/msa/clustalo/>) [@B43] was used to build the phylogenetic tree of pre-miRNA of miR-27a. Transcription factor binding sites in the promoter of mouse miR-27a were predicted using the TFBIND (<http://tfbind.hgc.jp/>) software. The potential target sites of miRNAs were predicted by TargetScan (<http://www.targetscan.org/>).

Plasmid construction
--------------------

The promoter fragments of miR-27a was amplified using primers promoter-PF and promoter-PR. The purified PCR products were cloned into the *pMD18-T* vector (TaKaRa, China). Then the recombinant plasmids were double-digested with *Nhe*I and *Hin*dIII (Thermo) and ligated into the *pGL3*-Basic vector (Promega). Mouse *p53* (NM_001127233.1) and *NFAT5* (NM_018823.2) CDS were amplified and double-digested with E*coR*I and *Xho*I (Thermo) and cloned into the *pcDNA3.1*(+) vector (Invitrogen, USA). The mouse *NFAT5* 3\'-UTR were amplified, double-digested with *Pme*I and *Xho*I, and then cloned into the *pmirGLO* vector (Promega, USA). The binding site mutants were generated using a MutanBEST Kit (TaKaRa, China) and mutagenic primers. The primers are described in Table [1](#T1){ref-type="table"}.

RNA interference
----------------

The synthesized siRNA of *p53* (si-p53) and *NFAT5* (si-NFAT5) and siRNA NC (RiboBio, China) was transfected into cells with Lipofectamine RNAiMAX (Invitrogen). After 48 and 72 h, cells were measured for Dual-luciferase reporter assays, qRT-PCR assays and western blot assays, respectively. The siRNA sequences are as follows: siRNA-p53 sense sequence: 5′-GAAUGAGGCCUUAGAGUUAdTdT-3′, antisense sequence: 3′-dTdTCUUACUCCGGAAUCUCAAU-5′; siRNA-NFAT5 sense sequence: 5′-GCUGGUGCUUUGAAUGUAAdTdT-3′; antisense sequenc: 3′-dTdTCGACCACGAAACUUACAUU-5′.

Chromatin immunoprecipitation (ChIP) assay
------------------------------------------

ChIP assays were performed using the EZ-ChIP™ Kit (Millipore, USA). Briefly, after crosslinking the chromatin with 1 % formaldehyde at 37 ◦C for 10 min and neutralizing with glycine for 5 min at room temperature, Cells were washed with cold PBS, scraped and collected on ice. Then, cells were harvested, lysed and sonicated. Nuclear lysates were sonicated 20 times for 10 s with 20 min intervals on ice water using a Vibra-Cell™ Processors VCX130 (Sonics, USA). An equal amount of chromatin was immuno-precipitated at 4 ◦C overnight with at least 1.5 μg of Anti-p53 (ab1101, Abcam, USA) and normal mouse IgG (Millipore, USA) antibodies. Immuno-precipitated products were collected after incubation with Protein A+G coated magnetic beads. The beads were washed, and the bound chromatin was eluted in ChIP elution buffer. Then the proteins were digested with Proteinase K for 4 h at 45 ◦C. Purified DNA from the samples and the input were analyzed for the presence of miR-27a promoter sequences containing putative *p53* response elements using qRT-PCR. The primers used here are listed in Table [1](#T1){ref-type="table"}.

Quantitative real-time polymerase chain reaction (qRT-PCR) analysis
-------------------------------------------------------------------

Total RNA (including miRNA) was extracted from tissues or cells with TRIzol reagent (Invitrogen, USA). Cellular RNA was extracted 48 h after transfection. One μg of RNA was treated with 1 μl *DNa*se I (Thermo Fisher, USA) to remove DNA contamination. Reverse transcription was performed using a RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher, USA). Random primers, oligo(dT)18 or miRNA specific stem-loop primers were added to initiate cDNA synthesis. qRT-PCR was performed on the Bio-Rad CFX96 system (Bio-Rad, USA) using iTaq Universal SYBR Green Supermix (Bio-Rad, USA). Primers used in the qRT-PCR were shown in Table [1](#T1){ref-type="table"}. qRT-PCR conditions consisted of 1 cycle at 94 °C for 3 min, followed by 40 cycles at 94 °C for 20 sec, 60 °C for 20 sec, and 72 °C for 20 sec, with fluorescence acquisition at 74 °C. All PCRs were performed in triplicate and gene expression levels were quantified relatively to the expression of β-actin using Gene Expression Macro software (Bio-Rad) by employing 2^-ΔΔCt^ value [@B44].

Western blotting analysis
-------------------------

Cell protein lysates were generated using RIPA Lysis Buffer (Beyotime, China). Cellular proteins were extracted 72 h after transfection. Western blotting was performed as reported previously [@B45]. Five μg proteins were boiled in 5 × SDS buffer for 5 min, separated by SDS-PAGE, and transferred to PVDF membranes (Millipore, USA). Then, the membranes were blocked with skim milk and probed with Anti-p53 (A0263, abclonal, USA), Anti-NFAT5 (Bs-9473R, bioss,China), Anti-β-catenin (Ab32572, Abcam, USA), Anti-c-myc (Ab32072, Abcam, USA), Anti-Bcl-2 (12789-1-ap, Proteintech, China). β-actin (ab8226, Santa Cruz, USA) was used as a loading control. The results were visualized with horseradish peroxidase-conjugated secondary antibodies (Santa Cruz) and enhanced chemiluminescence. All blots were performed in triplicate and protein expression levels were quantified relatively to the expression of β-actin using the Image J 1.42q software (Wayne Rasband).

EdU proliferation assay
-----------------------

Proliferating granulosa cells were determined using the Cell-LightTM EdU DNA Cell Proliferation Kit (Ribobio, China). Briefly, at the indicated time point after cell transfection, 50 μM EdU was applied to the cultures and the cells were grown for 2h. Then, the cells were fixed with 4% formaldehyde in PBS for 30 min. After labeling, the granulosa cells were assayed according to the manufacturer\'s protocol. Analysis of granulosa cell proliferation (ratio of EdU+ to all granulosa cells) was performed using images of randomly selected fields obtained on a florescent microscope (Nikon Eclipse Ti-S, USA). Assays were done three times using triplicate wells.

Statistical analysis
--------------------

Statistical analyses based on the two-tailed Student\'s t-test were performed using the Statistical Package for the Social Sciences software. Significance was determined at the 95% confidence interval. All data were expressed as the mean ± standard deviation (S.D.) from a representative experiment.
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![miR-27a was highly conserved in mammals. (A) The mature sequences of miR-27a were obtained from miRBase. The sequences of seed region were highlighted in red. mmu, mus musculus; rno, rattus norvegicus; hsa, homo sapiens; cgr, cricetulus griseus; bta, bos taurus; chi, capra hircus; ptr, pan troglodytes; ggo, gorilla gorilla; eca, equus caballus; ssc, sus scrofa. (B) The phylogenetic tree of miR-27a pre-miRNA. pre-miRNA sequences were obtained from NCBI.](ijbsv15p0287g001){#F1}

![miR-27a was downregulated by *p53* gene. CHO-K1 cells were transfected with *pc-p53*, *pcDNA3.1* and si-p53, NC. (A) qRT-PCR was used to detect endogenous *p53* mRNA 24 h after transfection. (B) Western blot analysis was used to detect p53 protein expression levels 48 h after transfection. (C) Twenty-four hours after transfection, the expression levels of miR-27a were determined by qRT-PCR. The data are represented as mean±S.D. of three independent experiments. \*\*\* *P* \< 0.001.](ijbsv15p0287g002){#F2}

![Identification of the binding sites of *p53* in the promoter regions of miR-27a. (A) Promoter activities of miR-27a promoter determined by luciferase assay. (B) Schematic diagram of the *p53* binding sites in the miR-27a promoter. (C) Luciferase activity was analyzed 24h after CHO-K1 cells were co-transfected with miR-27a-promoter and *pc-p53*, *pcDNA3.1*, si-p53 or NC. (D) site-directed mutagenesis in the*p53* binding sites of the miR-27a promoter were analyzed using luciferase assays. (E) ChIP assay of *p53* binding to the miR-27a promoter in CHO-K1 cells in vivo. DNA isolated from immunoprecipitated material was amplified by qRT-PCR total chromatin was used as the input. Normal mouse IgG was used as a negative control. The data are represented as mean±S.D. of three independent experiments. \* *P* \< 0.05, \*\* *P* \< 0.01, \*\*\* *P* \< 0.001.](ijbsv15p0287g003){#F3}

![Identification of *NFAT5* gene as a direct target of miR-27a in CHO-K1 cells. (A) Binding sites for miR-27a in the 3ˈ-UTR of *NFAT5* gene predicted by TargetScan. Red characters indicate sequences that were mutated to abolish the interaction between miR-27a and the *NFAT5* 3ˈ-UTR. (B) The miR-27a binding site (Red) of different species in the *NFAT5* 3ˈ-UTR. (C) miR-27a mimics were transfected into CHO-K1 cells together with the *pmirGLO-NFAT5* and *pmirGLO-NFAT5-mut* plasmid. Mimics NC was used as a negative control. (D) Endogenous *NFAT5* mRNA levels were detected 24 h after CHO-K1 cells were transfected with mimics, mimics NC, inhibitor and inhibitor NC of miR-27a. (E) Western blot analysis was used to detect endogenous NFAT5 protein expression level 48 h after CHO-K1 cells were transfected with mimics, mimics NC, inhibitor and inhibitor NC of miR-27a. (F) Endogenous *NFAT5* mRNA levels were detected 24 h after CHO-K1 cells were transfected with *pc-p53*, *pcDNA3.1*, si-p53 or NC. (G) Western blot analysis was used to detect endogenous NFAT5 protein expression level 48 h after CHO-K1 cells were transfected with *pc-p53*, *pcDNA3.1*, si-p53 or NC.The data are represented as mean ± S.D. of three independent experiments. \*\* *P* \< 0.01, \*\*\* *P* \< 0.001.](ijbsv15p0287g004){#F4}

![*NFAT5* regulated the downstream genes of the Wnt signaling pathway. CHO-K1 cells were transfected with *pc-NFAT5*, *pcDNA3.1* and si-NFAT5, NC. (A) qRT-PCR was used to detect endogenous *NFAT5* mRNA 24 h after transfection. (B) Western blot analysis was used to detect NFAT5 protein expression levels 48 h after transfection. (C, D) Twenty-four hours after transfection, the expression levels of *β-catenin* and *Bcl-2* were determined by qRT-PCR. (E) Western blot analysis was used to detect endogenous β-catenin and Bcl-2 protein expression level. The data are represented as mean±S.D. of three independent experiments. \* *P* \< 0.05, \*\*\* *P* \< 0.001.](ijbsv15p0287g005){#F5}

![Mouse GCs apoptosis induced by*NFAT5* gene. (A) Mouse GCs were labeled with EdU (Red). Cell nuclei were also visualized by Hoechst staining (Blue). The images were representative of the results obtained. (B) The percentage of proliferating GCs was expressed as the ratio of EdU cells to total Hoechst cells. Data were presented as mean ± S.D. from nine independent experiments. \*\*\* *P* \< 0.001.](ijbsv15p0287g006){#F6}

![A schematic illustration of the proposed model depicting a p53/miR-27a/NFAT5 mediated regulatory pathway in mouse GCs.](ijbsv15p0287g007){#F7}
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Primer sequences

  Name               Sequence (5\'-3\')
  ------------------ ---------------------------------------------------------
  promoter-PF        CTAGCTAGCAACTCATCATGTAGCTTAAGCA
  promoter-PR        CCCAAGCTTTTTGCTGTGGACCTTGCTCA
  pc-p53-PF          CACTAGTCCAGTGTGGTGGAATTCATGACTGCCATGGAGGAGTCAC
  pc-p53-PR          AACGGGCCCTCTAGACTCGAGTCAGTCTGAGTCAGGCCCCAC
  pc-NFAT5-PF        ACTATAGGGAGACCCAAGCTGGCTAGCGCCACCATGCCCTCGGACTTCATCTCAT
  pc-NFAT5-PR        GGTTTAAACGGGCCCTCTAGACTCGAGCTAAAAGGAGCCGGTTAAATTGTTC
  p53-QPCR-PF        TCGTCCTTTGTCCCTTCTCAG
  p53-QPCR-PR        CACCACCTCGGTCATGTACTCT
  NFAT5-QPCR-PF      CTCCTCAGATCCAGTTGGTTCA
  NFAT5-QPCR-PR      GCTGCATGTCTGGTTGGTTTAT
  p53-mut-PF         TGGGGTGGGGTTATGTAGTCACTGGCTGGGGAGGAG
  p53-mut-PR         CTCCTCCCCAGCCAGTGACTACATAACCCCACCCCA
  mmu-U6-Loop        CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGAAAAATATGGAACGCT
  mmu-U6-PF          CTGGTAGGGTGCTCGCTTCGGCAG
  mmu-U6-PR          CAACTGGTGTCGTGGAGTCGGC
  mmu-miR-27a-Loop   CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGGCGGAACT
  mmu-miR-27a-PF     TCGGCAGGTTCACAGTGGCTAAG
  mmu-miR-27a-PR     TCAACTGGTGTCGTGGAGTCGGC
  ChIP-mut4-PF       CTCTCCATGGCCCCATTTG
  ChIP-mut4-PR       CTGCTTCCCACTCTGCATCTATC
  ChIP-mut6-PF       AGCATCCAGCAGCCTCGC
  ChIP-mut6-PR       CACCCTAGCCCTCCTCTACTTC
  ChIP-mut10-PF      TCACTGTGCCTCGGACGGCT
  ChIP-mut10-PR      TTTGCTGTGGACCTTGCTCA

Note: PF was upstream primer. PR was downstream primer. The part highlighted with red was enzyme site induced.
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